should News newsbot.ch

Wirtschaft »

Roche and Spark Therapeutics, Inc. announce expected refiling date of Premerger Notification and Report Forms under the HSR Act and extension of tender offer for shares of Spark Therapeutics, Inc.

2019-05-14 05:20:02


Wirtschaft »

Roche and Spark Therapeutics, Inc. announce withdrawal and refiling of Premerger Notification and Report Form under the HSR Act and extension of tender offer for shares of Spark Therapeutics, Inc.

2019-04-03 15:40:15


Inland »

"The corals of Aqaba and the Red Sea, where science and diplomacy come together" (en)

2019-03-19 15:52:01


Wirtschaft »

FDA approves Roche’s Tecentriq in combination with chemotherapy for the initial treatment of adults with extensive-stage small cell lung cancer

2019-03-19 07:20:00


Wirtschaft »

European Commission approves Roche’s MabThera (rituximab) for a rare autoimmune disease

European Commission approves Roche’s MabThera (rituximab) for a rare autoimmune disease

2019-03-15 10:20:24


Wirtschaft »

Roche commences tender offer for all shares of Spark Therapeutics, Inc. for US$ 114.50 per share in cash

2019-03-07 19:20:03


Wirtschaft »

Roche und Spark Therapeutics schliessen verbindliche Übernahmevereinbarung

2019-02-25 19:20:33


Wirtschaft »

Roche enters into definitive merger agreement to acquire Spark Therapeutics

2019-02-25 09:20:18


Wirtschaft »

FDA accepts Roche’s supplemental biologics license application for Tecentriq plus chemotherapy (Abraxane and carboplatin) for the initial treatment of metastatic non-squamous non-small cell lung cancer

2019-01-17 07:20:05



Suchresultate als RSS-Feed